Asymmetrex® LLC

Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell medicine. Asymmetrex®'s founder, President and CEO is a leading authority on the unique properties of adult tissue stem cells. Asymmetrex holds a rich portfolio of intellectual property for technologies that address major barriers to success in regenerative medicine. These include patented methods for mass-producing adult tissue stem cells and their differentiated derivatives; counting adult tissue stem cells; engineering adult tissues stem cells; and evaluating effects of new drug candidates on adult tissue stem cells.

Content by Asymmetrex® LLC

Asymmetrex® LLC has not yet contributed any content.

Current Magazine Issue Background Image

CURRENT ISSUE - May/June 2026

The ROI of Actionable Data

Break Down Silos by Ensuring Data Flows Seamlessly Between Instruments and Analytics Tools

Lab Manager May/June 2026 Cover Image